BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10158118)

  • 1. Taking control: the Validation Master Plan.
    Donawa ME
    Med Device Technol; 1995 Dec; 6(10):12-4. PubMed ID: 10158118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Working draft of the FDA GMP final rule (Part I).
    Donawa ME
    Med Device Technol; 1995 Oct; 6(8):13-22. PubMed ID: 10158125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US quality system requirements for software validation.
    Donawa ME
    Med Device Technol; 1998 Mar; 9(2):17-20. PubMed ID: 10186973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting European and US requirements for design and development documentation, Part II.
    Donawa ME
    Med Device Technol; 1996 Dec; 7(10):10-5. PubMed ID: 10164052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standards used in the regulation of medical device in USA].
    Hu W; Gu H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Nov; 21(11):1263-7. PubMed ID: 18069490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complying with US and European complaint handling requirements.
    Donawa ME
    Med Device Technol; 1997 Sep; 8(7):12-5. PubMed ID: 10174197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differing definitions of manufacturer.
    Donawa ME
    Med Device Technol; 1998; 9(6):14-7. PubMed ID: 10182120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA's Quality System Inspection Technique in Ireland.
    Higgins S
    Med Device Technol; 2001; 12(1):40-1. PubMed ID: 11317865
    [No Abstract]   [Full Text] [Related]  

  • 9. Complying with US and European change control requirements, Part II.
    Donawa ME
    Med Device Technol; 1997 Nov; 8(9):13-6. PubMed ID: 10174625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting European and US requirements for design and development documentation, Part I.
    Donawa ME
    Med Device Technol; 1996 Nov; 7(9):12-5. PubMed ID: 10163673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quality planning conundrum.
    Donawa ME
    Med Device Technol; 1999; 10(6):14-6. PubMed ID: 10623345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Servicing: meeting US and European quality system requirements.
    Donawa ME
    Med Device Technol; 1997 Mar; 8(2):16-8, 20, 22. PubMed ID: 10166364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; current good manufacturing practice (CGMP) final fule; quality system regulation--FDA. Final rule.
    Fed Regist; 1996 Oct; 61(195):52602-62. PubMed ID: 10168287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical device reporting: another final rule, Part I.
    Donawa M
    Med Device Technol; 2000 Mar; 11(2):40-2. PubMed ID: 10915493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and recognition of consensus standards in US premarket submissions.
    Donawa ME
    Med Device Technol; 1999 Mar; 10(2):13-7. PubMed ID: 10387610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful recruitment for medical device clinical studies.
    Donawa M
    Med Device Technol; 2004 Oct; 15(8):25-7. PubMed ID: 16225270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomedical regulatory standards development as an educational and design review process.
    Hays CV
    Med Instrum; 1978; 12(2):136. PubMed ID: 683038
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical device reporting: the US final rule.
    Donawa ME
    Med Device Technol; 1996 Mar; 7(2):14-6, 18, 20-1. PubMed ID: 10159867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complying with US and European change control requirements, Part I.
    Donawa ME
    Med Device Technol; 1997 Oct; 8(8):10-3. PubMed ID: 10174270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidance on submitting quality system information.
    Donawa ME
    Med Device Technol; 2004 Mar; 15(2):24-7. PubMed ID: 15154336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.